A potential new way to predict which patients with head and neck cancer may benefit most from chemotherapy has been identified by researchers. These patients commonly receive pre-treatment induction chemotherapy, before either surgery or radiotherapy, to reduce the risk of disease spread. However the effectiveness of such treatment is reduced in tumors with poor blood flow.